Tiziana Life Sciences Ltd
TLSA
$1.18
$0.054.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.37% | -22.20% | 6.46% | 21.37% | 32.94% |
| Total Depreciation and Amortization | 88.71% | 69.16% | 45.63% | 37.69% | 29.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -78.75% | -33.12% | 77.78% | 135.70% | 209.43% |
| Change in Net Operating Assets | 654.71% | -118.36% | -174.33% | -220.93% | 65.11% |
| Cash from Operations | -741.87% | -297.57% | -123.99% | 47.59% | 90.28% |
| Capital Expenditure | -10.53% | 3.03% | 21.43% | -114.29% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 695.00% | 388.60% | 244.30% | -- |
| Cash from Investing | 16,115.79% | 672.89% | 383.53% | 241.81% | 98.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -39.01% | -8.22% | 20.53% | 3.33% | -18.49% |
| Issuance of Common Stock | 118.55% | 375.44% | 48,116.00% | 33,300.00% | 18,484.00% |
| Repurchase of Common Stock | -- | 0.00% | -- | 59.06% | 79.53% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -64.44% | -- | -- | -- |
| Cash from Financing | 124.70% | 390.54% | 131,922.22% | 8,107.35% | 2,190.61% |
| Foreign Exchange rate Adjustments | 122.89% | 121.34% | 120.32% | 56.51% | -1,210.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.74% | 318.97% | 211.96% | 138.66% | 115.00% |